BTG : Directorate Change

BTG plc: Appointment of Non-executive Director

London, UK, 23 January 2018: BTG plc (LSE: BTG) the specialist healthcare company, today announces the appointment of Anne Thorburn as a non-executive director of the Board and member of the Audit Committee.

Anne has an extensive range of international financial management, risk, audit and M&A experience. She was Chief Financial Officer of Exova Group plc from 2009 to 2015 and previously served as Group Finance Director at British Polythene Industries PLC. Anne is a non-executive director and Chair of the Audit Committee at Diploma PLC and is a member of the Institute of Chartered Accountants in Scotland.

Garry Watts, BTG's Chairman, commented: 'We are pleased to welcome Anne to the Board. She brings significant financial and broad business experience to BTG's Board, which will benefit the Company as we continue to implement our growth plans.'

There are no further details to be disclosed in relation to paragraph 9.6.13R of the Financial Conduct Authority Listing Rules.

BTG plc LEI number: 213800DCVRNVRVINH968.

For further information please contact:

BTG FTI Consulting

Andy Burrows, VP, Corporate & Investor Relations Ben Atwell/Simon Conway

[phone]; Mobile: [phone][phone]

Stuart Hunt, Investor Relations Manager

[phone]; Mobile: [phone]

About BTG

BTG is an international specialist healthcare company that is developing and commercializing products targeting acute care, cancer and vascular diseases. The company has diversified revenues from sales of its own marketed products and from royalties on partnered products, and is seeking to acquire new programs and products to develop and market to specialist physicians.

For further information about BTG please visit our website at www.btgplc.com.